causal

Biotech Companies Die From Running Out of Money

Biotech companies rarely fail because a trial fails or the FDA rejects them; they fail because they run out of money, so keeping the company well capitalized is the survival priority.

causalpending

Speaker

John Crowley

Evidence Quote

“Biotech companies only fail for one reason. It's not because a trial fails, and they get a bad letter from the FDA. Because they run out of money”

Source

Biotech’s Chief Evangelist— Joys of Compounding
Created: 11/18/2026, 9:59:31 AM

Your notes

Loading notes...